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Abstract – Neurodegeneration and gliosis are the main neuropathological features of prion diseases.
However, the molecular mechanisms involved in these processes remain unclear. Several studies have
demonstrated changes in the expression of apoptotic factors and inﬂammatory cytokines in animals with
experimental infection. Here we present the expression proﬁles of 15 genes implicated in the intrinsic and
extrinsic apoptotic pathways in the central nervous systems of sheep naturally infected with scrapie.
Expression changes obtained by real-time RT-PCR were also compared with the extent of classical scrapie
lesions, such as prion deposition, neuronal vacuolisation, spongiosis, and astrogliosis as well as with the
activation of caspase-3, using a stepwise regression. The results suggest that the factors assessed participate
in apoptotic or inﬂammatory functions, depending on the affected area. The mitochondrial apoptosis
pathway was associated with prion deposition in the prefrontal cortex (the less affected area), and with
activation of caspase-3-mediated cell death via over-expression of BAK. In addition to its known association
with astroglial activation, the extrinsic apoptosis pathway was also related to cell death and neuronal
vacuolisation.
apoptosis / prion / scrapie / mitochondrial pathway / extrinsic pathway
1. INTRODUCTION
Prion diseases or Transmissible Spongi-
form Encephalopathies (TSE), which include
Creutzfeldt-Jakob Disease (CJD) in humans,
Bovine Spongiform Encephalopathy (BSE) in
cattle, and scrapie in sheep and goats, are fatal
disorders that are produced by prions, which
are a type of unconventional agent that targets
the central nervous system (CNS) in mammals.
All forms of prion disease are associated with
an accumulation of abnormal isoforms of the
prion protein (PrP
Sc) in nervous tissues. The
neurological lesions of these diseases include
spongiform changes, gliosis, and neuronal
degeneration [4, 19]. Astrocytes also appear to
be targets for the scrapie agent in the CNS
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Article published by EDP Sciences[8, 22], and the disease condition results in
widespread astrogliosis.
Neurodegeneration is the main neuropatho-
logical feature of prion diseases; however, the
molecular mechanisms involved in prion-
induced cell death remain unclear. Several
studiesofscrapie-infectedsheep,mice,andham-
sters have shown that apoptosis is a common
cause of neuronal cell death in animal prion
disease [34, 42]. Similarly, apoptosis has been
considered as a common form of neuronal death
in CJD and fatal familial insomnia [12].
Initiation of apoptosis has been broadly
separated into two main pathways: (1) the
extrinsic or death receptor pathway and (2)
the intrinsic or mitochondrial pathway [9, 16].
Mitochondria play a central role in the regula-
tion of apoptosis [3, 21]. Numerous signalling
molecules, as well as pathological stimuli,
converge in this organelle, inducing the
release of pro-apoptotic molecules into the
cytoplasm. Mitochondrial membrane perme-
ability is directly controlled by the Bcl-2 family
of proteins [13, 33], and the sensitivity of cells
to apoptotic stimuli can depend on the balance
of pro and anti-apoptotic Bcl-2 proteins. The
role of Bcl-2 family proteins in prion disease
has not been extensively investigated.
Furthermore, few studies have been devoted
to investigating the implications of the extrinsic
apoptosis pathway in the neuropathology
induced by prions [17, 26, 34]. This regulatory
pathway is also related to the inﬂammation
induced in different neurodegenerative diseases
[28, 44]. In addition, the neuronal apoptosis
described in some TSE has been associated
with the presence of inﬂammatory cells and
cytokines [32, 38].
Analysis offactors involved in the regulation
of these apoptotic pathways will be useful in
clarifying the pathogenic mechanisms responsi-
ble for prion diseases. Here we report the gene
expression analysis of ﬁfteen genes that encode
regulatory factors involved in the mitochondrial
and extrinsic pathways of apoptosis in different
regions of the CNS of sheep naturally infected
with scrapie. Finally, we investigated the rela-
tionship between the regulation of these path-
ways and the presence of neuropathological
features of scrapie.
2. MATERIALS AND METHODS
2.1. Sample selection
Thirteen female Rasa aragonesa sheep were
included in the present study. Scrapie was diagnosed
in vivo in 8 sheep by means of neurological
examination and/or third eyelid biopsy [40]. When
these animals were sacriﬁced, all exhibited clinical
signs of scrapie in a terminal state. The diagnosis
was conﬁrmed using rapid tests and immunohisto-
chemical techniques to detect PrP
Sc [2]. The animals
were from a closed regulatory monitored ﬂock and
from the Spanish Scrapie Surveillance Programme.
Five control animals of the same breed were selected
from a different ﬂock in which no scrapie cases have
been reported to date. All animals analysed were 3 to
6 years old and displayed the ARQ/ARQ genotype
for PRNP, which is the most susceptible genotype
in this breed of animals [1]. Care and handling of
the animals were performed according to the rules
established by the National Research Council’s
guide.
Animals were sacriﬁced by intravenous injection
of sodium pentobarbital and exsanguination.
Necropsy did not reveal any other pathological signs
upon physical examination of the scrapie-infected
or control animals. Immediately after sacriﬁce, sam-
ples from the medulla oblongata, diencephalon, cere-
bellum, and prefrontal cortex were harvested from
each sheep. Because the histopathological lesions of
scrapie are bilateral, half of these samples were
placed in RNAlater
 (Ambion, Austin, TX, USA)
for 24 h at 4 C and then frozen at –80 Cu n t i l
RNA extraction. The other half were formalin-ﬁxed
and parafﬁn-embedded for further histopathological
analysis.
2.2. Total RNA isolation and cDNA synthesis
Total RNAwas isolated from tissue samples using
the RNeasy Lipid Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instruc-
tions. In order to avoid contamination with genomic
DNA, the samples were treated with two units of
TURBO DNase (Ambion) for 25 min at 37 C.
The RNA concentration was assessed with a Nano-
Drop ND-100 Spectrophotometer (Wilmington, DE,
USA), and its quality was determined by denaturing
formaldehyde agarose gel electrophoresis, which
revealed sharp and intense 18S and 28S rRNA bands.
Complementary DNA for each animal and CNS
region was synthesised from 2 lg of total RNA using
random hexamers and the Superscript First Strand
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CA, USA). Parallel reactions without reverse trans-
criptase enzyme were conducted to conﬁrm the
complete elimination of genomic DNA.
2.3. Real-time quantitative PCR
The expression of ﬁfteen genes involved in apop-
tosis regulation was evaluated using quantitative real-
time RT-PCR. Primer express 2.0 software (Applied
Biosystems, Foster City, CA, USA) was used to
design primers and probes based on known ovine
and bovine sequences. Primer design accounted for
gene structure, and combinations of forward and
reverse primers were designed in different exons.
When using heterologous primers, the resulting
PCR fragments were puriﬁed with either the Nucleo-
Spin Extract kit (Macherey-Nagel, Du ¨ren, Germany)
or reactive EXOSAP-IT (USB, Cleveland, OH,
USA) and bidirectionally sequenced with the PCR
primers using the Big Dye Terminator Cycle
Sequencing kit and ABI PRISM 3100 system
(Applied Biosystems). The identity of the PCR prod-
ucts was conﬁrmed by BLAST comparison with the
GenBank database. The accession numbers for
the new ovine cDNA sequences and the length of
t h eR T - P C Rp r o d u c t sa r es h o w ni nTable I.
Gene expression was analysed using SYBR

Green (PE Applied Biosystems) assays. A dissocia-
tion curve protocol was run after every real-time
RT-PCR reaction in order to identify the presence
of spurious PCR bands or high levels of primer
dimers. These artefacts were observed for the
BCL2, BCL-XL, MCL1, and FASL genes. In these
cases, expression was analysed using TaqMan probes
designed to recognise the exon-exon boundaries. The
appropriate primers and probes used for ampliﬁcation
of all genes, as well as their concentrations, are
shown in Table I.
Real-time RT-PCR ampliﬁcations were performed
in an ABI-Prism 7000 Sequence Detection System
(PE Applied Biosystems). All real-time RT-PCR
reactions were run in triplicate in a total reaction vol-
ume of 10 lL using 10-20 ng of cDNA as the tem-
plate. Ampliﬁcation of cDNA by PCR was
achieved using universal cycling conditions, with
an initial 10 min activation and denaturation step at
95 C, followed by 40 cycles of 15 s at 95 Ca n d
30 s at the suitable annealing temperature (Tab. I).
The levels of gene expression were determined by
the comparative Ct method.
A normalisation factor (NF) was used to
determine the expression level of each gene in
each sample, according to the recommendation of
Vandesompele et al. [39]. The NF was calculated as
the geometric mean of the quantity (Q) of the 3 or
4 most stable housekeeping genes (from a total of
eight) in each tissue (GAPDH, SDHA, and HPRT
for the prefrontal cortex; YWHAZ, SDHA, GAPDH,
and G6PDH for the diencephalon; G6PDH, SDHA,
and ACTB for the cerebellum; and G6PDH, GAPDH,
and RPL32 for the medulla oblongata). Primers and
probes used for housekeeping gene ampliﬁcation as
well as the procedure for arranging these genes based
on the order of their stability will be described else-
where (Lyahyai et al., unpublished results
1).
2.4. Histopathology and immunohistochemistry
The histopathological study of samples obtained
from the medulla oblongata, diencephalon, prefrontal
cortex, and cerebellum was performed using haema-
toxylin-eosin stained slices (one from each animal).
The extent of neuronal vacuolation and neuropil
spongiosis was evaluated in these stained sections
and scored on a scale ranging from 0–5 (0 = no neu-
ron/neuropil vacuolation or gliosis and 5 = substan-
tial lesions throughout the region).
PrP
Sc detection was performed for adjacent
sections, as previously described [15]. Brieﬂy, after
pretreatment with 98% formic acid, hydrated auto-
claving, and digestion with proteinase K (4 lg/mL),
the sections were incubated with endogenous perox-
idase blocking reagent (DAKO, Glostrup, Denmark)
for 10 min. The sections were then incubated with
monoclonal primary antibody L42 (R-Biopharm,
Germany; dilution 1:500) at RT for 30 min. The
enzyme-conjugated polymer Envision (DAKO,
Glostrup, Denmark; 30 min) was used as the visual-
isation system, and DAB (DAKO; 10 min) was used
as the chromogen. The sections were counterstained
by treatment with haematoxylin.
Astrogliosis was evaluated on the basis of glial
ﬁbrillary acidic protein (GFAP) immunostaining,
and induction of caspase-dependent apoptosis was
evaluated by immunohistochemical detection of the
active form of caspase-3. In both cases, after heat-
induced epitope retrieval pretreatment with citrate
buffer (pH 6.0), the sections were incubated for 1 h
at RT with the appropriate primary antibody.
The antibodies employed recognise GFAP (rabbit
polyclonal, 1:400, DAKO) and caspase-3 (mouse
monoclonal Ab-4, 1:40, Calbiochem, Darmstadt,
1 Lyahyai J., Serrano C., Ranera B., et al., Effect of
scrapie on the stability of housekeeping genes,
Anim. Biotechnol. (submitted).
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Page 4 of 12 (page number not for citation purpose)Germany), and the caspase-3 antibody preferentially
reacts with the 11 kDa caspase-3 molecule, which
is the activated form of caspase-3. In routine immu-
noreactions, sheep lymph node tissue sections were
included as positive controls, whereas omission of
primary antibodies in control and scrapie slides
served as negative controls.
Global quantiﬁcation of PrP
Sc, GFAP, and cas-
pase-3 was also determined using the same scoring
system ranging from 0 to 5 (0 = weak immunoreac-
tivity and 5 = strong immunoreactivity). The subjec-
tive scores were carried out by two observers.
2.5. Statistics
Quantitative results obtained from real-time
RT-PCR assays are expressed as mean ± standard
error of the mean values. Gene expression means
for the control group were arbitrarily standardised
to 1.0, and data for the scrapie-infected group were
compared based on this calibrator. The student t-test
analysis was applied to determine whether the differ-
ences observed between groups were statistically sig-
niﬁcant (P <0 . 0 5 ) .
To score the neuropathological and immunohisto-
chemical features of scrapie, the differences between
controls and scrapie-infected sheep were assessed
using the non-parametric Mann-Whitney test. The
effect of area on the intensity of anatomopathological
lesions and immunostaining was analysed using the
Kruskal-Wallis test. The scores were plotted as a
function of the anatomical area, and data are
expressed as mean ± standard deviation.
Principal component analysis was performed
using the covariance matrix to study the magnitude
of co-expression for apoptotic pathways. Genes were
grouped according to their participation in the extrin-
sic and mitochondrial apoptosis pathways and their
known functions in these pathways (see Tab. II).
T h ep r e v i o u s l yr e p o r t e de x p r e s s i o nd a t af o rBAX,
which is a pro-apoptotic BCL2 member, were
included in these analyses [24].
Table II. Association between gene expression and prion-related lesions in 4 CNS areas. Genes are
classiﬁed in 7 groups according to their role in apoptotic pathways. P1: BAX, BAD, BAK, BCLXS, BCL2,
BCLXL, MCL1, AIF, APAF1, PARP1 (mitochondrial pathway); P1a: BAX, BAD, BAK, BCLXS (pro-
apoptotic Bcl-2 family factors); P1b: BCL2, BCLXL, MCL1 (anti-apoptotic Bcl-2 family factors); P1c: AIF,
APAF1, PARP1 (other apoptosis factors); P2: FAS, FASL, TNFA, TNFR1, TNFR2, TGFB (extrinsic
pathway); P2a: FAS, TNFR1, TNFR2 (receptors); P2b: FASL, TNFA, TGFB (ligands). Lesions: Pr (prion
deposition); Sp (neuropil spongiosis); Vac (neuronal vacuolisation) and Ag (astrogliosis). PC: percentage of
the variability explained by the ﬁrst principal component of each group. Signiﬁcant P-values (P < 0.05)
obtained using a stepwise regression between the ﬁrst principal component of each group and the lesions are
shown. (ns: not statistically signiﬁcant).
Expression of apoptosis genes in scrapie Vet. Res. (2009) 40:42
(page number not for citation purpose) Page 5 of 12We also studied the relationship between the gene
expression proﬁles of each gene or the ﬁrst principal
component of the apoptotic pathways and histopa-
thological lesions by a stepwise regression with for-
ward selection and backward elimination set at
P < 0.1. The model used for analysis of each combi-
nation of gene or principal component and tissue was
the following:
yi ¼l þ b1pri þ b2nvi þ b3spi þ b4asi
þ b5cpi þ ei
where yi is the gene expression proﬁle of the ith indi-
vidual; pri, nvi, spi, asi,a n dcpi represent numerical
evaluations of the ith individual for PrP
Sc,n e u r o n a l
vacuolisation, spongiosis, astrogliosis, and activation
of caspase-3, respectively; b1, b2, b3, b4, and b5 are
the slopes of the multiple regression associated with
each variable; and ei is the residual.
Finally, a Bonferroni correction was performed
within tissue to correct for multiple testing. The sta-
tistical analyses were performed using either SPSS
(Chicago, IL, USA) or STATISTIX (Analitical
Software, Tallahassee, FL, USA).
3. RESULTS
3.1. Gene expression proﬁles
The expression of 15 genes that encode
proteins involved in the regulation of the
mitochondrial and extrinsic pathways of apop-
tosis was analysed in 4 different areas of the
CNS of scrapie-infected and control sheep.
Samples that were treated and untreated with
reverse transcriptase showed differences of
more than 6 cycles for every gene, indicating
that genomic DNA was successfully removed
(data not shown). Standard curves for all ana-
lysed factors displayed appropriate slopes and
correlation values (Tab. I).
The expression proﬁles varied according to
the area analysed (Fig. 1). In scrapie-infected
medullaoblongata,3genesinvolvedintheregu-
lationofthe mitochondrialpathwayof apoptosis
(BCL-XS, MCL1, AIF) and 3 genes involved in
theextrinsicpathway(TNFA,TNFR2,FAS)were
signiﬁcantly over-expressed.
Figure 1. Expression proﬁles of 15 genes implicated in the intrinsic and extrinsic apoptotic pathways in the
medulla oblongata, diencephalon, cerebellum, and prefrontal cortex of control (grey bar) and naturally-
infected scrapie sheep (black bar). Signiﬁcant differences were detected using the Student t-test. * P < 0.05.
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of the pro-apoptotic genes BAK and FAS were
signiﬁcantly increased. The level of FASL was
very low in both scrapie and control dienceph-
alons, which rendered quantiﬁcation difﬁcult.
In the cerebellum, changes in expression
were only signiﬁcant for anti-apoptotic genes.
BCL2 and BCL-XL were down-regulated, and
an increase in MCL1 was observed. Similarly,
slight but signiﬁcant decreases in BCL-XL and
APAF1 were detected in scrapie-infected
prefrontal cortex. In this tissue, BAK was
up-regulated. The differences in the expression
of genes involved in the extrinsic pathway of
apoptosis were not signiﬁcant in either the pre-
frontal cortex or cerebellum.
3.2. Scrapie-related lesions
The neuropathological features of scrapie
were evaluated in the 4 CNS areas of 5 control
and 9 scrapie-infected sheep.
Neuronal vacuolisation was only detected in
affected animals, and the highest lesion levels
were observed in the medulla oblongata and
diencephalon (Fig. 2). The Kruskal-Wallis test
revealed a signiﬁcant effect of area with regards
to this feature. Besides the high variability
observed in the scrapie group, the differences
compared to controls were statistically signiﬁ-
cant for the diencephalon (P <0 . 0 5 ) .
Neuropil spongiosis was observed in both
groups of animals (Fig. 2). In the infected sheep,
spongiosis scoring was stable in all analysed
regions. In contrast, the control group displayed
signiﬁcant differences between areas (Kruskal-
Wallis P < 0.05) due to the low levels of spongi-
osis observed in the prefrontal cortex. The
Mann-Whitney test showed that the increase in
lesions in scrapie animals was statistically signif-
icant(P < 0.05)inallareasexceptthecerebellum.
The effect of the CNS area in prion deposi-
tion was also statistically signiﬁcant (P < 0.01).
The origin of this difference was the low level
of PrP
Sc immunostaining observed in the pre-
frontal cortex (Fig. 2).
Astrogliosis was evaluated by GFAP detec-
tion. A generalised increase in the astroglial
Figure 2. Scoring of histopathological lesions in each analysed area. Scores for neuronal vacuolation,
neuropil spongiosis, prion deposition and reactive gliosis (GFAP) are shown as means ± standard error.
Black bars: control sheep, grey bars: scrapie-infected sheep. Areas: medulla oblongata (MO), diencephalon
(D), prefrontal cortex (PFC), and cerebellum (Cb). Student t-test * P < 0.05, ** P < 0.01.
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affected cases (Fig. 2). Apparent hyperplasia
and hypertrophy of stellate-shaped astrogial
cells was observed in both the grey and white
matter when compared to control brains, indic-
ative of reactive astrogliosis. Differences
between areas were not observed in either
control or infected sheep.
Finally, cell death was also analysed by
immunodetection of the activated form of cas-
pase-3 using an antibody that preferentially
reacts with the activated form of this protein.
In general, very weak staining was observed
in the different CNS sections, and it was not
signiﬁcantly different between the scrapie and
control groups (data not shown).
3.3. Relationship between expression proﬁles
and histopathological lesions
The analysed genes were grouped according
to their known functions in the apoptotic path-
ways. In most cases, the ﬁrst principal compo-
nent represented more than 60% of the total
variability, indicating a common regulation of
the genes involved in each speciﬁc pathway
(Tab. II).
Prion deposition was positively associated
with the ﬁrst principal component of the mito-
chondrial apoptosis pathway in the prefrontal
cortex, as demonstrated by the statistical signif-
icance of its covariate in the stepwise regression
analysis. This association is apparent in the
up-regulation of BAK (Tab. III). The expression
change contributes to the positive association
observed between the pro-apoptotic group of
Bcl-2 factors and the activation of caspase-3.
The extrinsic pathway was also associated with
prion immunostaining in the same region.
Astrogliosis was positively associated with
the extrinsic pathway in the medulla oblongata
and prefrontal cortex.
Neuropil spongiosis exhibited a signiﬁcant
association with both the ﬁrst principal compo-
nent of the death receptor group and that of the
ligand group in the cerebellum. The covariate of
the ligand sub-group was also related to neuro-
nal vacuolisation in the medulla oblongata.
Finally, after Bonferroni correction for multi-
ple testing, the stepwise regression between
BAK and prion deposition in the prefrontal cor-
t e xr e m a i n e ds i g n i ﬁ c a n t .
4. DISCUSSION
Apoptosis has been widely considered as
one of the main types of Programmed Cell
Death that causes neurodegeneration in prion
diseases [10, 23, 37]. A comprehensive under-
standing of the molecular mechanisms that reg-
ulate apoptosis and their relationship to the
presence of PrP
Sc or other prion-related lesions
may provide new targets for future treatments
of human diseases.
In the present work, the expression proﬁles
of ﬁfteen genes involved in the mitochondrial
and extrinsic pathways of apoptosis were ana-
lysed in the CNS of sheep that were naturally
infected with scrapie. Distinct expression pro-
ﬁles were found in each CNS region, indicating
that different mechanisms could be involved in
TSE-related cell death, depending on the area
(Fig. 1).
On the one hand, expression changes com-
patible with apoptosis induction were detected
via over-expression of pro-apoptotic genes
(BAK, BCL-XS, AIF, FAS, TNFA, TNFR2)i n
different areas or down-regulation of the anti-
apoptotic genes BCL2 and BCL-XL in the pre-
frontal cortex. The reduced mRNA levels of
BCL2 and BCL-XL play a primary role in
PrP
-/- neuronal cell death [30], as well as in
other neurodegenerative diseases exhibiting
anomalous protein accumulation, such as spi-
nocerebellar ataxia types 3 [7]a n d7[ 41]o r
Alzheimer disease [46].
On the other hand, the decrease in APAF1
expression in scrapie prefrontal cortex and the
up-regulation of MCL1 observed in the medulla
oblongata and cerebellum of scrapie animals
suggest the presence of anti-apoptotic mecha-
nisms. In this context, the Apaf-1 deﬁciency
confers resistance to cyt-c-dependent caspase
activation and apoptosis in vitro [18, 43]a n d
in vivo [36, 45]. In addition, the interaction
of Mcl-1 with different pro-apoptotic Bcl-2
members, such as Bax and Bak, inhibits the
opening of the mitochondrial permeability tran-
sition pore [5, 47] and subsequent activation of
Vet. Res. (2009) 40:42 C. Serrano et al.
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pro and anti-apoptotic mechanisms are acti-
vated in prion-infected tissues.
In order to determine any possible associa-
tion between the scrapie lesions and the induc-
tion of a speciﬁc apoptotic pathway, stepwise
regressions were performed between the gene
expression data and the prion-related lesions.
Although we are aware that the histopatholo-
gical valuation does not correspond to a real
scale, our procedure can reliably detect the
dependence between the different parameters.
However, these results are not meant to serve
in a predictive capacity.
Table III. Association between individual gene expression levels and histopathological scrapie lesions in
four analysed CNS areas. The table shows signiﬁcant P-values (P < 0.1) obtained by Stepwise regression
analysis. (ns: not statistically signiﬁcant). Lesions: Pr (prion deposition); Sp (neuropil spongiosis); Vac
(neuronal vacuolisation) and Ag (astrogliosis).
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deposition was positively associated with the
ﬁrst principal component of the mitochondrial
apoptosis pathway in the prefrontal cortex,
which was one of the less affected areas. This
was mainly evident for BAK expression. The
reliability of this BAK/prion association was
conﬁrmed after Bonferroni correction. Over-
expression of BAK has been reported in other
neurodegenerative diseases, such as Alzheimer
disease [20, 29], but never before in prion dis-
eases. In our study, up-regulation of BAK was
associated with the presence of the active form
of caspase-3 in the prefrontal cortex. This result
indicates that this factor can play an important
role in neurodegeneration during the early
stages of prion disease, when the levels of
PrP
Sc are still relatively low. In addition, the
neuroprotectiveroleofPrP
Cseemstobespeciﬁc
for BAX-mediated apoptosis, and it is unable to
arrest BAK-mediated cellular death [27].
Different factors comprising the death recep-
tor pathway of apoptosis have been implicated
in the neuronal death that occurs in different
prion disease models [35]. For instance, cere-
bella from CJD patients exhibit an increase in
Fas and Fas ligand proteins [26]. Although
the increase in FASL, TNFR2, and TGFB
observed herein was not signiﬁcant, the step-
wise regression analysis revealed a positive
association between the sub-groups of this path-
way and spongiosis. This speciﬁc apoptosis
pathway could then participate in scrapie-
induced cellular loss in the cerebellum.
Our statistical analysis also demonstrated a
relationship between the ligand sub-group,
and neuronal vacuolisation in the medulla
oblongata. To our knowledge, this is the ﬁrst
time that this relationship has been reported,
although a known association exists between
Fas and TNF-alpha with glial and neuronal
vacuolisation in other brainstem neurodegener-
ative models [6].
Our research shows that the extrinsic path-
way of apoptosis had a positive association with
astrogliosis in the medulla oblongata and the
prefrontal cortex. This association has been
previously reported. TNFR2 can participate in
cellular apoptosis [14], as well as in inﬂamma-
tion [31], and the increase in Fas has also been
associated with reactive gliosis and neuroin-
ﬂammation [11, 25].
In conclusion, our ﬁndings indicate that the
mitochondrial apoptosis pathway is activated
during early stages of prion deposition via
up-regulation of BAK. In addition, induction
of the extrinsic pathway is related to the reac-
tive gliosis and neuronal loss that occur in
sheep naturally infected with scrapie. These
data provide new clues to further understand
the molecular pathways that regulate cell death
in prion diseases.
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